Correlation of c-met proto-oncogene and insulin-like growth factor-1 receptor (IGF-1R) in metastazising uveal melanoma.

被引：0
|
作者：
Ericsson, CB
Bartolazzi, A
Seregard, S
Larsson, O
机构：
[1] Karolinska Inst, St Eriks Eye Hosp, Stockholm, Sweden
[2] Karolinska Hosp, Dept Pathol & Oncol, S-17176 Stockholm, Sweden
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2001年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1160
引用
收藏
页码：S216 / S216
页数：1
相关论文
共 50 条
  • [31] Clinical development of insulin-like growth factor receptor—1 (IGF-1R) inhibitors: At the crossroad?
    Andrea Gombos
    Otto Metzger-Filho
    Lissandra Dal Lago
    Ahmad Awada-Hussein
    Investigational New Drugs, 2012, 30 : 2433 - 2442
  • [32] Immunolocalization of the insulin like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) in the ovary of the bitch
    Cardilli, D. J.
    Oliveira, K. S.
    Joao, C. F.
    Voorwald, F. A.
    Silva, M. A. M.
    Oliveria, J. A.
    Toniollo, G. H.
    Perez-Gutierrez, J. F.
    REPRODUCTION IN DOMESTIC ANIMALS, 2012, 47 : 116 - 117
  • [33] Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma
    Ueki, T
    Fujimoto, J
    Suzuki, T
    Yamamoto, H
    Okamoto, E
    HEPATOLOGY, 1997, 25 (04) : 862 - 866
  • [34] TIVANTINIB Proto-oncogene c-Met Inhibitor Hepatocyte Growth Factor Receptor Inhibitor Oncolytic
    Pento, J. Thomas
    DRUGS OF THE FUTURE, 2011, 36 (12) : 893 - 898
  • [35] Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma
    Ueki, T
    Fujimoto, J
    Suzuki, T
    Yamamoto, H
    Okamoto, E
    HEPATOLOGY, 1997, 25 (03) : 619 - 623
  • [36] Polymorphisms of insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) contribute to pathologic progression in childhood IgA nephropathy
    Hahn, Won-Ho
    Suh, Jin-Soon
    Cho, Byoung-Soo
    GROWTH FACTORS, 2011, 29 (01) : 8 - 13
  • [37] Expression of insulin-like growth factor-1 receptor (IGF-1R) as a marker of response to erlotinib in pancreatic ductal adenocarcinoma (PDA).
    Witkiewicz, A.
    Valsecchi, M. E.
    Brody, J. R.
    Simon, L. R.
    Yeo, C.
    Carr, B. I.
    Solomides, C.
    Peiper, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] IMMUNOHISTOCHEMICAL EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR (IGF-1R) AND ITS ASSOCIATION WITH CLINICOPATHOLOGICAL PARAMETERS IN HEPATOCELLULAR CARCINOMA
    Maia, Maria Luiza Peloso
    Albuquerque, Ronniel Morais
    do Carmo Silva, Serena Dafne
    Lima, Cristiano Xavier
    Diniz, Paulo Henrique Costa
    Vidgal, Paula Vieira Teixeira
    ONCOLOGY, 2024, 102 (06) : 494 - 502
  • [39] Insulin-like growth factor-1 receptor (IGF-1R) expression in liposarcoma as a potential target for therapy. A pilot study
    Mourad, W. A.
    DiFrancesco, L.
    TUMOR BIOLOGY, 2012, 33 : 105 - 105
  • [40] Functional Collaboration of Insulin-Like Growth Factor-1 Receptor (IGF-1R), but Not Insulin Receptor (IR), With Acute GH Signaling in Mouse Calvarial Cells
    Gan, Yujun
    Paterson, Andrew J.
    Zhang, Yue
    Jiang, Jing
    Frank, Stuart J.
    ENDOCRINOLOGY, 2014, 155 (03) : 1000 - 1009
12345